Literature DB >> 33928576

siRNA Vehicles for High Endosomal Escapability.

Hiroyuki Koide1, Sei Yonezawa1, Tomohiro Asai2.   

Abstract

Small interfering RNA (siRNA) is a novel therapeutic modality for the treatment of intractable diseases; however, the development of a useful siRNA delivery vector is imperative for clinical use. Since siRNA works in the cytoplasm, the ability of the carrier to escape destruction in the endosomes is a highly required characteristic for the induction of a high knockdown effect. Here, we describe the step-by-step procedure for the evaluation of high endosomal escapability. The vector that has pH-responsive characteristics at around pH = 6.2-6.5 is important for the high endosomal escape.

Keywords:  Confocal image; Endosome; Lipid nanoparticle; Small interfering RNA; pH-responsive vehicle

Year:  2021        PMID: 33928576     DOI: 10.1007/978-1-0716-1298-9_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

Review 1.  Nonviral delivery of synthetic siRNAs in vivo.

Authors:  Saghir Akhtar; Ibrahim F Benter
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

2.  Chemically modified symmetric and asymmetric duplex RNAs: an enhanced stability to nuclease degradation and gene silencing effect.

Authors:  Takanori Kubo; Zhivko Zhelev; Hideki Ohba; Rumiana Bakalova
Journal:  Biochem Biophys Res Commun       Date:  2007-10-29       Impact factor: 3.575

3.  Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape.

Authors:  Jerome Gilleron; William Querbes; Anja Zeigerer; Anna Borodovsky; Giovanni Marsico; Undine Schubert; Kevin Manygoats; Sarah Seifert; Cordula Andree; Martin Stöter; Hila Epstein-Barash; Ligang Zhang; Victor Koteliansky; Kevin Fitzgerald; Eugenio Fava; Marc Bickle; Yannis Kalaidzidis; Akin Akinc; Martin Maier; Marino Zerial
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

4.  Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.

Authors:  Christopher A Alabi; Kevin T Love; Gaurav Sahay; Hao Yin; Kathryn M Luly; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

Review 5.  Overcoming cellular barriers for RNA therapeutics.

Authors:  Steven F Dowdy
Journal:  Nat Biotechnol       Date:  2017-02-27       Impact factor: 54.908

6.  Engineering the Binding Kinetics of Synthetic Polymer Nanoparticles for siRNA Delivery.

Authors:  Hiroyuki Koide; Tatsuya Fukuta; Anna Okishim; Saki Ariizumi; Chiaki Kiyokawa; Hiroki Tsuchida; Masahiko Nakamoto; Keiichi Yoshimatsu; Hidenori Ando; Takehisa Dewa; Tomohiro Asai; Naoto Oku; Yu Hoshino; Kenneth J Shea
Journal:  Biomacromolecules       Date:  2019-09-30       Impact factor: 6.988

7.  Key determinants of siRNA delivery mediated by unique pH-responsive lipid-based liposomes.

Authors:  Mariko Sako; Furan Song; Ayaka Okamoto; Hiroyuki Koide; Takehisa Dewa; Naoto Oku; Tomohiro Asai
Journal:  Int J Pharm       Date:  2019-08-12       Impact factor: 5.875

8.  Rigorous control of vesicle-forming lipid pKa by fluorine-conjugated bioisosteres for gene-silencing with siRNA.

Authors:  Ayaka Okamoto; Hiroyuki Koide; Naoki Morita; Yusuke Hirai; Yuji Kawato; Hiromichi Egami; Yoshitaka Hamashima; Tomohiro Asai; Takehisa Dewa; Naoto Oku
Journal:  J Control Release       Date:  2018-12-26       Impact factor: 9.776

9.  Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo.

Authors:  Muthusamy Jayaraman; Steven M Ansell; Barbara L Mui; Ying K Tam; Jianxin Chen; Xinyao Du; David Butler; Laxman Eltepu; Shigeo Matsuda; Jayaprakash K Narayanannair; Kallanthottathil G Rajeev; Ismail M Hafez; Akin Akinc; Martin A Maier; Mark A Tracy; Pieter R Cullis; Thomas D Madden; Muthiah Manoharan; Michael J Hope
Journal:  Angew Chem Int Ed Engl       Date:  2012-07-10       Impact factor: 15.336

Review 10.  Interfering with disease: a progress report on siRNA-based therapeutics.

Authors:  Antonin de Fougerolles; Hans-Peter Vornlocher; John Maraganore; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

  10 in total
  1 in total

1.  Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles.

Authors:  Yusuke Hirai; Hisaaki Hirose; Miki Imanishi; Tomohiro Asai; Shiroh Futaki
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.